Centre for Eye Health, University of New South Wales, Sydney, NSW, 2052, Australia.
School of Optometry and Vision Science, University of New South Wales, Sydney, NSW, 2052, Australia.
Sci Rep. 2022 May 6;12(1):7442. doi: 10.1038/s41598-022-11070-6.
Drusen are a hallmark lesion of age-related macular degeneration (AMD) and changes in their area and/or volume are strongly associated with disease progression. Assessment of longitudinal change in drusen size in clinical practice however is limited to a single commercial tool or manual inspection by clinicians. In this study we analysed change in drusen area in 33 eyes with intermediate AMD across two separate visits using a novel technique known as multispectral pattern recognition for en face retinal images from various imaging modalities (infrared (815 nm), fundus autofluorescence (488 nm) and green (532 nm) scanning laser ophthalmoscopy). We found 91% (30/33 eyes) agreement in the direction of drusen change for multispectral pattern recognition relative to expert graders who graded eyes as having drusen progression, regression or being stable. Multispectral pattern recognition showed 100% sensitivity (22/22 eyes) and 73% specificity (8/11 eyes). In comparison, we found only 70% (23/33 eyes) agreement in the direction of drusen change with a commercially available change analysis software, the Cirrus Advanced RPE Analysis relative to expert graders, with a sensitivity 64% (14/22 eyes) and specificity of 82% (9/11 eyes). Total drusen area or amount of change between visits had no significant effect on agreement. This suggests multispectral pattern recognition can quantify longitudinal change in drusen area from multimodal imaging with greater congruency to expert graders than a commercially available platform based on a single imaging modality. Considering the association of drusen area and disease progression, this method could aid clinical assessment and monitoring of AMD.
在年龄相关性黄斑变性(AMD)中,玻璃膜疣是标志性病变,其面积和/或体积的变化与疾病进展密切相关。然而,在临床实践中,对玻璃膜疣大小的纵向变化的评估仅限于单一的商业工具或临床医生的手动检查。在这项研究中,我们使用一种新的技术,即多光谱模式识别,对来自不同成像模式(红外(815nm)、眼底自发荧光(488nm)和绿色(532nm)扫描激光检眼镜)的额状视网膜图像,分析了 33 只中间型 AMD 眼中玻璃膜疣面积的变化。我们发现,与将眼睛分级为玻璃膜疣进展、消退或稳定的专家分级者相比,多光谱模式识别在玻璃膜疣变化方向上的一致性为 91%(30/33 只眼)。多光谱模式识别显示 100%的敏感性(22/22 只眼)和 73%的特异性(8/11 只眼)。相比之下,我们发现,与专家分级者相比,与商业上可用的变分析软件 Cirrus Advanced RPE Analysis 在玻璃膜疣变化方向上的一致性仅为 70%(23/33 只眼),敏感性为 64%(14/22 只眼),特异性为 82%(9/11 只眼)。两次就诊之间的总玻璃膜疣面积或变化量对一致性没有显著影响。这表明,与基于单一成像模式的商业上可用平台相比,多光谱模式识别可以更符合专家分级者地定量分析来自多模态成像的玻璃膜疣面积的纵向变化。考虑到玻璃膜疣面积与疾病进展的相关性,这种方法可以帮助进行 AMD 的临床评估和监测。